ROME (ITALPRESS) – The U.S. Food and Drug Administration (FDA) has cleared ZYN nicotine sachets, making them the first and only product in their class to receive clearance in the United States. FDA clearance of all ZYN nicotine sachets currently marketed by Swedish Match in the United States, a memo explains, “is an important step in protecting public health by making available to adult smokers viable alternatives to cigarettes and other traditional tobacco products.””It is estimated that 45 million Americans regularly consume nicotine and about 30 million of them smoke cigarettes, the most harmful form of nicotine use,” said Tom Hayes, president of Swedish Match North America LLC. “The FDA’s decision recognizes the role ZYN can play with regard to protecting public health by helping people quit cigarettes and other traditional tobacco products.The FDA has cleared the following products: ZYN Cool Mint 3 mg; ZYN Cool Mint 6 mg; ZYN Peppermint 3 mg; ZYN Peppermint 6 mg; ZYN Spearmint 3 mg; ZYN Spearmint 6 mg; ZYN Wintergreen 3 mg; ZYN Wintergreen 6 mg; ZYN Citrus 3 mg; ZYN Citrus 6 mg; ZYN Coffee 3 mg; ZYN Coffee 6 mg; ZYN Cinnamon 3 mg; ZYN Cinnamon 6 mg; ZYN Smooth 3 mg; ZYN Smooth 6 mg; ZYN Chill 3 mg; ZYN Chill 6 mg; ZYN Menthol 3 mg; ZYN Menthol 6 mg.
– Photo Ipa Agency -(ITALPRESS).
